Back
ESC Premium Access

Effects of tafamidis in patients with transthyretin amyloid cardiomyopathy

Session: Poster Session 1 - Inflammatory, infiltrative and cardiomyopathy
Topic: Treatment
Speaker: Doctor R. Rettl (Vienna, AT)
Event: ESC Congress 2019

Congress Presentation

Add to my library

Like

About the speaker

Doctor Rene Rettl

Medical University of Vienna, Vienna (Austria)
0 follower

9 more presentations in this session

Apical sparing in patients without cardiac amyloidosis

Speaker: Ms C. Binder (Vienna, AT)

Access
Abstract
Like
Thumbnail

Diagnostic utility of tissue biopsy in transthyretin cardiac amyloidosis diagnosed by non-invasive diagnostic criteria

Speaker: Doctor M. Nishi (Kumamoto, JP)

Access
Abstract
Like
Thumbnail

Association of acroparesthesias and angiokeratomas with the alpha-galactosidase A gene polymorphisms in females with hypertrophic cardiomyopathy

Speaker: Miss A. Polyakova (Saint Petersburg, RU)

Access
Abstract
Slides
Like
Thumbnail

Long-term evolution of Fabry cardiomyopathy under enzyme replacement therapy in the Swiss Fabry cohort. An echocardiographic study

Speaker: Doctor P. Monney (Lausanne, CH)

Access
Abstract
Like
Thumbnail

Electrocardiographic findings in Anderson-Fabry disease versus sarcomeric hypertrophic cardiomyopathy

Speaker: Doctor G. Vitale (Bologna, IT)

Access
Abstract
Like
Thumbnail

Access the full session

Poster Session 1 - Inflammatory, infiltrative and cardiomyopathy

Speakers: Doctor R. Rettl, Ms C. Binder, Doctor M. Nishi, Miss A. Polyakova, Doctor P. Monney...
Access
Like
Thumbnail

About the event

Image

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources